Roshy Pakdaman

Roshy Pakdaman has over 20 years of experience in the pharmaceutical industry. Roshy is currently the Vice President of Pharmaceutical Development at REVOLUTION Medicines, a position they have held since 2023. Prior to this, they held various leadership roles at Gilead Sciences, including Vice President of Pharmaceutical Development & Technology, Vice President of Formulation & Process Development, Executive Director, Senior Director, Director, and Senior Scientist. Roshy has also worked as a Visiting Researcher at Caltech, where they conducted electron transfer studies, and as an Associate Professor and ATER at Université Denis Diderot, where they conducted research on human serum transferrin receptor. Roshy completed a Postdoctoral Fellowship at the University of New Hampshire, where they focused on protein purification and characterization.

Roshy Pakdaman completed a Ph.D. in Physical Chemistry from Université Paris Cité between 1993 and 1997. Following that, they pursued a Postdoc in Physical Chemistry at the University of New Hampshire from 1998 to 1999.